silybin has been researched along with Cancer of Stomach in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, Y; Lou, D; Ping, X; Shi, W; Yu, M; Zhang, Y | 1 |
| Cai, H; Jiang, G; Wang, YX; Wu, H; Zhou, TB | 1 |
| Choe, JH; Choi, MG; Hur, SM; Kim, JH; Kim, JS; Kim, S; Kim, SH; Kim, WW; Lee, HS; Lee, JE; Lee, SK; Nam, SJ; Yang, JH | 1 |
3 other study(ies) available for silybin and Cancer of Stomach
| Article | Year |
|---|---|
Synergistic apoptotic effects of silibinin in enhancing paclitaxel toxicity in human gastric cancer cell lines.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Paclitaxel; Proto-Oncogene Proteins c-bcl-2; Silybin; Silymarin; Stomach Neoplasms | 2018 |
Silibinin inhibits proliferation, induces apoptosis and causes cell cycle arrest in human gastric cancer MGC803 cells via STAT3 pathway inhibition.
Topics: Antineoplastic Agents; Apoptosis; bcl-X Protein; Caspase 3; Caspase 9; CDC2 Protein Kinase; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclin B1; Cyclin-Dependent Kinases; Down-Regulation; Humans; Inhibitor of Apoptosis Proteins; M Phase Cell Cycle Checkpoints; Myeloid Cell Leukemia Sequence 1 Protein; RNA, Messenger; Silybin; Silymarin; STAT3 Transcription Factor; Stomach Neoplasms; Survivin | 2014 |
Silibinin suppresses TNF-alpha-induced MMP-9 expression in gastric cancer cells through inhibition of the MAPK pathway.
Topics: Blotting, Western; Cell Line, Tumor; Cell Proliferation; Flow Cytometry; Gene Expression Regulation; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Reverse Transcriptase Polymerase Chain Reaction; Silybin; Silymarin; Stomach Neoplasms; Tumor Necrosis Factor-alpha | 2009 |